The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries.
Find more information at www.bayer.com and http://radiology.bayer.com/congresses/upcoming-congresses
Bracco Imaging S.p.A. is one of the World's leading companies in the diagnostic imaging business. Part of Bracco S.p.A., the holding company of Bracco Group, Bracco Imaging operates in over 80 markets worldwide, either directly or indirectly through subsidiaries, joint ventures, license and distribution partnership agreements. Headquartered in Milan, Italy, Bracco Imaging is one of the independent global players providing a large portfolio of imaging agents. Bracco Imaging's portfolio offering has been broadened with the acquisition of E-Z-EM, Inc., a major manufacturer of contrast media and medical devices for gastrointestinal (GI) radiology. The portfolio of Bracco Imaging offers products and solutions for all key diagnostic imaging modalities: X-Ray Imaging (including Computed Tomography-CT), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound and Nuclear Medicine through radioactive tracers.
Find more information at www.bracco.com
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest. GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.
Find more information at www.gehealthcare.com
Guerbet is a pioneer in the contrast agent field with 90 years of experience and is the only pharmaceutical group dedicated to medical imaging worldwide. It offers a comprehensive range of X-Ray, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve the diagnosis and treatment of patients. With 7% of its revenue consecrated to R&D and more than 200 employees distributed amongst its three centers in France and the United States, Guerbet is a substantial investor in research and innovation. Guerbet (GBT) is listed on Euronext Paris (Segment B – Mid Caps) and generated €776 million in revenue in 2016.
For more information about Guerbet, please visit www.guerbet.com